This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...th severe or critical COVID-19, and modifies previous recommendations for the neutralizing monoclonal antibodies sotrovimab and casirivimab-imdevimab in patients with non-severe COVID-19.
more
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...ology issues there are still insufficient data to make a recommendation, in which case different options for approaching VE evaluations are presented.
more
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document aims to encourage countries to develop and implement policies to maintain and strengthen IPC programmes and measures in health care facilities in the context of the current ongoing transmission of the SARS-CoV-2, with recognition that epidemiological trends may vary and the risk of tra...nsmission of other pathogens.
more
Note d'orientation 7 juin 2022.
Ce document a pour but d'encourager les pays à élaborer et à mettre en œuvre des politiques visant à maintenir et à renforcer les programmes et mesures de prévention des infections dans les établissements de soins de santé dans le contexte de la transmission... actuelle du SRAS-CoV-2, tout en reconnaissant que les tendances épidémiologiques peuvent varier et que le risque de transmission d'autres agents pathogènes existe.
more
The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compounded the already difficult task the Region was facing in moving towards universal health coverage (UHC) attainment.
This document contains summary information on the latest projections from the IHME model on COVID-19
in Brazil. The model was run on July 15, 2022, with data through July 13, 2022.
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises. WHO continues to support countries in adjusting COVID-19 strategies to reflect succ...esses to date and leverage what has been learned through national responses.
To assist national and global efforts to end the COVID-19 emergency worldwide, WHO updated the COVID-19 (Global Preparedness, Readiness and Response plan) in 2022 and outlined two strategic objectives.
more
This Commission report aims to contribute to a new era of multilateral cooperation based on strong UN institutions to reduce the dangers of COVID-19, forestall the next pandemic, and enable the world to achieve the agreed goals of sustainable development, human rights, and peace that governments are... committed to pursue as members of the UN. We address this Commission report to the UN member states, the UN agencies and multilateral institutions, and multilateral processes such as the G20 and the G7.
more
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...ey solutions on the road to equitable access to diagnostics and therapeutics.
This report draws from experience gained through the Access to COVID-19 Tools (ACT) Accelerator Diagnostics and Therapeutics pillars, and includes the perspectives of collaborating stakeholders (countries, civil society representatives and the private sector). Building on these findings, this report proposes sixteen recommended actions to address what have been identified as key structural challenges and specifies a potential owner for each action.
more
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...ntinue to have access to COVID-19 tools in the longer term, while maintaining the coalition’s readiness to help address future disease surges.
Developed through a consultative process with ACT-A agencies, donors, industry partners, civil society organizations (CSOs) and Facilitation Council members, the plan summarizes priority areas of focus for the partnership’s pillars, coordination mechanisms and other core functions, and highlights the work to be maintained, transitioned, sunset, or kept on standby.
more
Les notes d’orientation décrivent les mesures essentielles que les décideurs nationaux et infranationaux peuvent mettre en place concernant les aspects suivants de la lutte contre la COVID-19 : les tests de diagnostic, la prise en charge clinique, la réalisation des cibles en matière de vaccin...ation, le maintien des mesures de lutte anti-infectieuse liées à la maladie dans les établissements de soins de santé, les efforts
visant à instaurer la confiance par la communication sur les risques et la participation communautaire ainsi que la gestion de l’infodémie liée à la COVID-19.
more
Les notes d’orientation décrivent les mesures essentielles que les décideurs aux niveaux national et infranational peuvent mettre en place concernant les aspects suivants : les tests de diagnostic de la COVID19, la prise en charge clinique de la COVID-19, la réalisation des cibles en matière ...de vaccination contre la
COVID-19, le maintien des mesures de lutte anti-infectieuse liées à la COVID-19 dans les établissements de soins de santé, les efforts visant à instaurer la confiance par la communication sur les risques et la participation communautaire ainsi que la gestion de l’infodémie liée à la COVID-19. La présente note d’orientation est axée sur la communication sur les risques et la participation communautaire dans le
contexte de la COVID-19.
more
The guidance notes describe key actions that policy-makers at national and subnational levels can take in relation to: diagnostic testing for COVID-19, clinical management of COVID-19, meeting targets for vaccination against COVID-19, maintaining infection control measures for COVID-19 in health-car...e settings, building confidence through risk communication and community involvement, and ensuring that all health-care workers are aware of the risks of COVID-19.
This guidance note focuses on the following areas: COVID-19 diagnostic testing, clinical management of COVID-19, achieving COVID-19 vaccination targets, maintaining COVID-19 infection control measures in health-care settings, building confidence through risk communication and community engagement, and managing COVID-19 infodemia. This guidance note focuses on risk communication and community engagement in the context of COVID-19.
more
La pratique infirmière avancée (PIA), telle qu’évoquée dans le présent document, se réfère aux services et
aux interventions de santé renforcés et étendus, assurés par des infirmières qui, grâce à des compétences avancées, influent sur les résultats des soins de santé cliniques ...et dispensent des services de santé directs à la personne, aux familles et aux collectivités (CNA, 2019; Hamric et Tracy, 2019). Une infirmière de pratique avancée (IPA) a acquis, grâce à une formation complémentaire, une base de connaissances spécialisées, des capacités perfectionnées en matière de prise de décision et des compétences cliniques pour une pratique infirmière plus étendue, dont les caractéristiques dépendent du contexte dans lequel elle est accréditée
à exercer ses fonctions (CII, 2008a). L’infirmière clinicienne spécialisée (ICS) et l’infirmière praticienne (IP)
sont les deux catégories d’IPA les plus généralement
more
This document aims to encourage countries to develop and implement policies to maintain and strengthen IPC programmes and measures in health care facilities in the context of the current ongoing transmission of the SARS-CoV-2, with recognition that epidemiological trends may vary and the risk of tra...nsmission of other pathogens.
more
Reseña normativa de la OMS:
La lutte contre l’épidémie de Covid-19 nous montre de manière cinglante que, sur le terrain de l’action en santé publique, les logiques de promotion de la santé sont bel et bien minoritaires. Pendant cette période de crise, la décision
politique et sanitaire se base largement sur un mod...le hygiéniste. Ce dernier s’est déployé comme si la promotion de la santé (appelée à devenir à ses origines une «nouvelle santé publique») n’avait jamais existé, comme si tout un corpus
d’enseignements n’avait pu franchir les murs des écoles, comme si un ensemble de pratiques menées depuis un demi-siècle à différentes échelles n’avaient pas démontré leur efficacité et été reconnues scientifiquement.
more
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of... the pandemic response capabilities united under COVAX may eventually be integrated into regional, national and sub national health systems, routine immunization programmes and future global pandemic preparedness and response (PPR) structures. Therefore, the working structures outlined in this document continue to evolve and the document provides a snapshot of the COVAX ways of working in the first half of 2022.
more